During the past decade, Zespó Przychodni Specjalistycznych PRIMA conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Zespó Przychodni Specjalistycznych PRIMA" are "Crohn Disease" (5 trials), "Ulcerative Colitis" (3 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Zespó Przychodni Specjalistycznych PRIMA" in a lesser frequency.

Most popular intervention types in "Zespó Przychodni Specjalistycznych PRIMA" are "Drug" (9 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Etrolizumab" (4 trials), "Ozanimod" (3 trials) and "Mesalamine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Zespó Przychodni Specjalistycznych PRIMA" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Zespó Przychodni Specjalistycznych PRIMA". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Zespó Przychodni Specjalistycznych PRIMA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Zespó Przychodni Specjalistycznych PRIMA, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".